These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 842489)

  • 41. [Insulin and proinsulin secretion under contraceptive steroid administration (author's transl)].
    Hausmann L; Goebel KM; Klähn D; Kaffarnik H
    Klin Wochenschr; 1975 Sep; 53(18):853-60. PubMed ID: 1165627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term profile of a new progestin.
    Lippman J
    Int J Fertil; 1992; 37 Suppl 4():218-22. PubMed ID: 1362189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced anaerobic glycolysis in oral contraceptive users.
    Vijayalakshmi R; Bamji MS; Ramalakshmi BA
    Contraception; 1988 Jul; 38(1):91-7. PubMed ID: 2971503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of ethynodiol diacetate and combination--type oral contraceptive compounds on carbohydrate metabolism. I. Six month intravenous glucose tolerance study.
    Goldman JA
    Diabetologia; 1975 Feb; 11(1):45-8. PubMed ID: 1140518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of oral contraceptive agents on copper and zinc balance in young women.
    Crews MG; Taper LJ; Ritchey SJ
    Am J Clin Nutr; 1980 Sep; 33(9):1940-5. PubMed ID: 7416062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aflatoxin and oral contraceptives.
    Nutr Rev; 1977 May; 35(5):110-1. PubMed ID: 325436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women. I. Blood and urinary lactate, uric acid, and phosphorus.
    Kelsay JL; Behall KM; Moser PB; Prather ES
    Am J Clin Nutr; 1977 Dec; 30(12):2016-22. PubMed ID: 930871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of oral contraceptives on plasma insulin and blood glucose levels after long term use (author's transl)].
    Muck BR; Hommel G
    Arch Gynakol; 1976; 221(1):61-72. PubMed ID: 989269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fertility regulation in nursing women: IV. Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth.
    Croxatto HB; Díaz S; Peralta O; Juez G; Herreros C; Casado ME; Salvatierra AM; Miranda P; Durán E
    Contraception; 1983 Jan; 27(1):13-25. PubMed ID: 6404596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of a high-fructose diet on glucose tolerance, plasma lipid and hemorheological parameters during oral contraceptive administration in female rats.
    Olatunji LA; Oyeyipo IP; Usman TO
    Clin Hemorheol Microcirc; 2013 Jan; 54(1):23-31. PubMed ID: 22648005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Some observations on the changes in capillary resistance in oral contraceptive users.
    Zaki K; Younis MN; Razek SA; Mekkawi TE; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):145-51. PubMed ID: 12256025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on low-dose oral contraceptives: cervical mucus and plasma hormone changes in relation to circulating D-norgestrel and 17alpha ethynyl-estradiol concentrations.
    Elstein M; Morris SE; Groom GV; Jenner DA; Scarisbrick JJ; Cameron EH
    Fertil Steril; 1976 Aug; 27(8):892-9. PubMed ID: 955131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes.
    Skouby SO; Kühl C; Mølsted-Pedersen L; Petersen K; Christensen MS
    Am J Obstet Gynecol; 1985 Nov; 153(5):495-500. PubMed ID: 3933351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic effects of the triphasic oral contraceptive Trigynon.
    Vermeulen A; Thiery M
    Contraception; 1982 Nov; 26(5):505-13. PubMed ID: 6761061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of synthetic oestrogens and progestagens in oral contraceptives on bile lipid composition.
    Down RH; Whiting MJ; Watts JM; Jones W
    Gut; 1983 Mar; 24(3):253-9. PubMed ID: 6826111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipids and blood coagulation studies in women using steroidal hormones for contraception.
    Hashmi JA; Kazi AB; Kazi A; Ali N
    J Pak Med Assoc (1951); 1972 Aug; 22(8):218-25. PubMed ID: 12305803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes.
    Skouby SO; Andersen O; Saurbrey N; Kühl C
    J Clin Endocrinol Metab; 1987 Mar; 64(3):519-23. PubMed ID: 3102539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of short-term treatment with a combined oestrogen-progestin oral contraceptive on biliary lipids and cholesterol saturation index in young women.
    Snowball S; Taylor W
    J Steroid Biochem; 1985 Feb; 22(2):257-61. PubMed ID: 3982033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Levels of protein S during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
    Jespersen J; Nielsen MT
    Gynecol Obstet Invest; 1989; 28(2):82-6. PubMed ID: 2529199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eight years of fertility control with norgestrel-ethinyl estradiol (Ovral): an updated clinical review.
    Korba VD; Heil CG
    Fertil Steril; 1975 Oct; 26(10):973-81. PubMed ID: 1183625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.